Lennox International Schedules Third Quarter Conference Call
Get Alerts LII Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.1%
EPS Growth %: -2.9%
Join SI Premium – FREE
DALLAS, Oct. 5, 2020 /PRNewswire/ -- Lennox International Inc. (NYSE: LII) today announced plans to report third quarter 2020 financial results before the market opens on Monday, October 19, 2020. A conference call is scheduled for the same day at 8:30 a.m. Central time. All interested parties are invited to listen as Chairman and CEO Todd Bluedorn and CFO Joe Reitmeier comment on the company's financial results and outlook, followed by Q&A.
To listen, call the conference call line at 877-336-4440 (U.S.) or 409-207-6984 (international) at least 10 minutes prior to the scheduled start time and use participant code 8252687. The conference call also will be webcast on Lennox International's web site at www.lennoxinternational.com.
A replay of the conference call will be available from approximately 11:00 a.m. Central time on October 19 through November 2, 2020 by dialing 866-207-1041 (U.S.) or 402-970-0847 (international) and using access code 9386544. The call also will be archived on the company's web site.
Lennox International Inc. is a global leader in the heating, air conditioning, and refrigeration markets. Lennox International stock is listed on the New York Stock Exchange and traded under the symbol "LII". Additional information is available at www.lennoxinternational.com or by contacting Steve Harrison, Vice President, Investor Relations, at 972-497-6670.
View original content to download multimedia:http://www.prnewswire.com/news-releases/lennox-international-schedules-third-quarter-conference-call-301145080.html
SOURCE Lennox International Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- The Inner Circle acknowledges, Michael M. Pennock, MD, MBiot, DABR as a Pinnacle Lifetime Member
- Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share